[Treatment of systemic scleroderma].
D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003078:Colchicine / Q000627:therapeutic use; D005176:Factor XIII / Q000627:therapeutic use; D006801:Humans; D010396:Penicillamine / Q000627:therapeutic use; D010951:Plasma Exchange; D011453:Prostaglandins / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy / Q000628:therapy*
D002121:Calcium Channel Blockers; D011453:Prostaglandins; D005176:Factor XIII; D002216:Captopril; D010396:Penicillamine; D003078:Colchicine
Traitement de la sclérodermie systémique.